BG Medicine's Heart Test Powers 175 Percent Revenue Growth in Q4 | GenomeWeb

NEW YORK (GenomeWeb News) – BG Medicine today reported a 175 percent increase year over year in revenues for the fourth quarter as product revenues increased more than three-fold.

The Waltham, Mass.-based firm said that revenues for the three months ended Dec. 31, 2012 totaled $1.1 million, up from $379,000 a year ago and beating the average analyst estimate of $940,000. Product revenues increased to $978,000 from $307,000 a year ago, and service revenues rose to $94,000 from $72,000, a 31 percent jump.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.